Profil Tatalaksana ICS/LABA pada Pasien Asma Persisten Sedang di Poliklinik Paru RS Prof. Chairuddin Panusunan Lubis Universitas Sumatera Utara

Riska Resti, Amira Permatasari Tarigan, Andika Pradana, Arlinda Sari Wahyuni

Abstract


Asma adalah penyakit heterogen kronis yang paling umum pada saluran pernapasan di wilayah Asia-Pasifik dengan tingkat kontrol asma tertinggi adalah asma yang terkontrol sebagian yaitu 63%, diikuti oleh asma yang tidak terkontrol sebesar 30% dan asma yang terkontrol penuh sebesar 7%. Tujuan penelitian adalah untuk mengetahui profil penggunaan ICS/LABA berdasarkan tingkat kontrol asma. Penelitian dilakukan dengan metode retrospektif kohort analitik menggunakan 61 rekam medis dari 1 Januari 2017 hingga 31 Desember 2019. Subjek penelitian adalah pasien dengan asma persisten sedang yang menerima terapi ICS/LABA selama minimal 3 bulan. Analisis statistik deskriptif digunakan untuk menilai profil pengobatan ICS/LABA pada hasil klinis. Jenis kelamin didominasi oleh perempuan sebanyak 48 orang (78,7%), rentang usia >41-50 tahun sebanyak 20 orang (32,8%). Pada karakteristik pengobatan didominasi oleh ICS/LABA jenis Diskus Salmeterol/Fluticason propionat dosis 50/250 mcg sebanyak 33 orang (54,1%) dan ICS/LABA jenis Turbuhaler Formoterol Fumarat/Budesonide dosis 4,5/160 mcg sebanyak 28 orang (45,9%). Proporsi tingkat kontrol asma tertinggi adalah asma terkontrol sebagian sebanyak 44 orang (70,5%). Profil penatalaksanaan yang bervariasi didapatkan dengan mayoritas penggunaan ICS/LABA adalah jenis Diskus Salmeterol/Fluticason propionat dengan dosis 50/250 mcg.

Kata Kunci : asma persisten sedang, ics/laba, profil tatalaksana


Keywords


asma persisten sedang, ics/laba, profil tatalaksana

References


Global Initiative for Asthma. Global strategy for asthma management and prevention. 2023 [cited 2023 Aug 27]; Available from: www.ginasthma.org

Wang Z, Li Y, Gao Y, Fu Y, Lin J, Lei X, et al. Global, regional, and national burden of asthma and its attributable risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Respir Res. 2023 Dec 1;24(1).

Barnes PJ. Drugs for asthma. Vol. 147, British Journal of Pharmacology. 2006.

Reilev M, Pottegård A, Davidsen JR, Rasmussen L, Søndergaard J, Laursen CB, et al. Seventeen-Year Nationwide Trends in Use of Long-acting Bronchodilators and Inhaled Corticosteroids among Adults – A Danish Drug Utilization Study. Basic Clin Pharmacol Toxicol. 2018 Jul 1;123(1):58–64.

Fingleton J, Hardy J, Baggott C, Pilcher J, Corin A, Hancox RC, et al. Description of the protocol for the PRACTICAL study: A randomised controlled trial of the efficacy and safety of ICS/LABA reliever therapy in asthma. BMJ Open Respir Res. 2017 Jul 1;4(1).

Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGeralde M, et al. Global strategy for asthma management and prevention: GINA executive summary. Vol. 31, European Respiratory Journal. European Respiratory Society; 2008. p. 143–78.

Scottish Intercollegiate Guidelines Network., British Thoracic Society., Healthcare Improvement Scotland. British guideline on the management of asthma: a national clinical guideline. Thorax. 2003 Feb;58 Suppl 1 (Suppl 1):i1-94.

Hardy J, Baggott C, Fingleton J, Reddel HK, Hancox RJ, Harwood M, et al. Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial. The Lancet. 2019 Sep 14;394(10202):919–28.

Bateman ED, Bousquet J, Keech ML, Busse WW, Clark TJH, Pedersen SE. The correlation between asthma control and health status: The GOAL study. European Respiratory Journal. 2007 Jan;29(1):59–63.

Palmqvist M, Ibsen T, Mellén A, Lötvall J. Comparison of the Relative Efficacy of Formoterol and Salmeterol in Asthmatic Patients [Internet]. Vol. 160, Am J Respir Crit Care Med. 1999. Available from: www.atsjournals.org

Anderson P. Patient preference for and satisfaction with inhaler devices. In: European Respiratory Review. European Respiratory Society; 2005. p. 109–16.

Borgstro¨m L, Borgstro¨m B, Asking L, Thorsson L, R& D A. Idealhalers or realhalers? A comparison of Diskus and Turbuhaler. J Clin Pract. 2005 Dec;59(12):1488-95.

Jahedi L, Downie SR, Saini B, Chan HK, Bosnic-Anticevich S. Inhaler Technique in Asthma: How Does It Relate to Patients’ Preferences and Attitudes Toward Their Inhalers? J Aerosol Med Pulm Drug Deliv. 2017 Feb 1;30(1):42–52.

Adachi M, Hozawa S, Nishikawa M, Yoshida A, Jinnai T, Tamura G. Asthma control and quality of life in a real-life setting: a cross-sectional study of adult asthma patients in Japan (ACQUIRE-2). Journal of Asthma. 2019;56(9):1016–25.

Price D, Fletcher M, Van Der Molen T. Asthma control and management in 8,000 European patients: The REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir Med. 2014 Jun 12;24.

Molimard M, Gros V Le. Impact of patient-related factors on asthma control. Journal of Asthma. 2008 Mar;45(2):109–13.

Yildiz F, Erbagci A, Demirel YS, Akcali SD, Ekici A, Dursunoglu N, et al. Importance of inhaler device use status in the control of asthma in adults: The asthma inhaler treatment study. Respir Care. 2014 Feb 1;59(2):223–30.

Gold LS, Thompson P, Salvi S, Faruqi RA, Sullivan SD. Level of asthma control and health care utilization in Asia-Pacific countries. Respir Med. 2014 Feb;108(2):271–7.

Kitch BT, Paltiel AD, Kuntz KM, Dockery DW, Schouten JP, Weiss ST, et al. A single measure of FEV1 is associated with risk of asthma attacks in long-term follow-up. Chest. 2004;126(6):1875–82.

Arnold DH, Gebretsadik T, Minton PA, Higgins S, Hartert T V. Clinical measures associated with FEV1 in persons with asthma requiring hospital admission. American Journal of Emergency Medicine. 2007 May;25(4):425–9.




DOI: https://doi.org/10.30596/amj.v8i2.23821

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Jurnal Kedokteran Anatomica/ Anatomica Medical Journal (AMJ)

Fakultas Kedokteran
Universitas Muhammadiyah Sumatera Utara, Indonesia
Kampus 1 Lantai II Laboratorium Anatomi
Jl. Gedung Arca No 53 Medan-Sumatera Utara, Indonesia.
E-mail: amj_fk@umsu.ac.id || Editorial Contact: 081375150018

Creative Commons License

This work is licensed under aCreative Commons Attribution-ShareAlike 4.0 International License.